Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly and | Switzerland | Healthcare | Pharmaceuticals | CHF 714.21B | 74.9x | CHF 790 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Roche Holding | Switzerland | Healthcare | Pharmaceuticals | CHF 251.51B | 28.6x | -1.02 | CHF 316 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.3% Upside | Upgrade to Pro+ | |
Roche Holding Participation | Switzerland | Healthcare | Pharmaceuticals | CHF 236.31B | 30.4x | -1.02 | CHF 296.80 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.1% Upside | Upgrade to Pro+ | |
Abbott Laboratories | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 210.07B | 17.5x | 0.13 | CHF 93.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novartis | Switzerland | Healthcare | Pharmaceuticals | CHF 192.89B | 18.3x | -1.01 | CHF 97.72 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novartis | Switzerland | Healthcare | Pharmaceuticals | CHF 192.89B | 18.3x | -1.01 | CHF 97.59 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.3% Upside | Upgrade to Pro+ | |
Lonza Group | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 42.18B | 58x | CHF 583.60 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.3% Upside | Upgrade to Pro+ | ||
Lonza Group | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 42.15B | 58x | CHF 583 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.3% Upside | Upgrade to Pro+ | ||
Alcon | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 40.01B | 38.3x | 0.25 | CHF 80.98 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.8% Upside | Upgrade to Pro+ | |
Straumann Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 20.92B | 77.3x | -2.52 | CHF 130.75 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.2% Upside | Upgrade to Pro+ | |
Sandoz | Switzerland | Healthcare | Pharmaceuticals | CHF 19.55B | -2,379.2x | 26.82 | CHF 41.65 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.6% Upside | Upgrade to Pro+ | |
Zimmer Biomet Holdings Inc | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 18.61B | 23.5x | -2.4 | CHF 109 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sonova Holding | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 18.03B | -5.42 | CHF 228.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Sonova H Ag | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 17.40B | 30.8x | -5.42 | CHF 291.80 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.3% Upside | Upgrade to Pro+ | |
Ypsomed Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 4.94B | 66.4x | 25.93 | CHF 361.50 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.5% Upside | Upgrade to Pro+ | |
BACHEM HOLDING AG | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 4.41B | 38.9x | 2.54 | CHF 58.90 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.4% Upside | Upgrade to Pro+ | |
Siegfried Holding Ltd | Switzerland | Healthcare | Pharmaceuticals | CHF 4.26B | 33x | -2.44 | CHF 994 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.4% Upside | Upgrade to Pro+ | |
Galenica Sante | Switzerland | Healthcare | Pharmaceuticals | CHF 4.07B | 23x | -0.71 | CHF 81.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.2% Downside | Upgrade to Pro+ | |
Dottikon Es Holding AG | Switzerland | Healthcare | Pharmaceuticals | CHF 2.95B | 39.2x | -3.16 | CHF 213.50 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lepu Medical Tech Beijing DRC | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 2.78B | 28.8x | -0.54 | CHF 16.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medacta | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 2.75B | 46.2x | 4.05 | CHF 137.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.8% Upside | Upgrade to Pro+ | |
Joincare Pharmaceutical DRC | Switzerland | Healthcare | Pharmaceuticals | CHF 2.70B | 14.7x | 4.97 | CHF 7.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BB Biotech | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 2.11B | 16.7x | 0.12 | CHF 38.35 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.7% Upside | Upgrade to Pro+ | |
BB Biotech | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 2.08B | 16.9x | 0.12 | CHF 38.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SKAN | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 1.71B | 55.9x | 2.97 | CHF 77.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.6% Upside | Upgrade to Pro+ | |
Aevis Victoria | Switzerland | Healthcare | Healthcare Providers & Services | CHF 1.18B | -40.2x | 0.02 | CHF 14 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSMO Pharma | Switzerland | Healthcare | Pharmaceuticals | CHF 1.09B | 16.6x | 0.03 | CHF 67.90 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.7% Upside | Upgrade to Pro+ | |
Medartis | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 1.01B | 237.5x | 1.54 | CHF 74 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.1% Upside | Upgrade to Pro+ | |
Kuros Biosciences | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 868.51M | -74.6x | -3.07 | CHF 22.85 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PolyPeptide Group AG | Switzerland | Healthcare | Pharmaceuticals | CHF 723.99M | -31.4x | -1.23 | CHF 22.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Basilea Pharmaceutica AG | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 551.60M | -845.4x | 7.38 | CHF 45.65 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.7% Upside | Upgrade to Pro+ | |
medmix | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 540.04M | -294.9x | 2.54 | CHF 13.50 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IVF Hartmann Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 340.57M | 19.5x | 0.59 | CHF 143 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coltene Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 325.06M | 26.3x | -0.55 | CHF 54.40 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.7% Upside | Upgrade to Pro+ | |
Newron Pharmaceuticals | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 208.77M | -10.8x | 0.68 | CHF 10.46 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Santhera Pharmaceuticals Holding | Switzerland | Healthcare | Pharmaceuticals | CHF 201.53M | 2.7x | 0.02 | CHF 16 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Molecular Partners AG | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 160.40M | -2.3x | 0.69 | CHF 4.35 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Idorsia | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 158.54M | -0.6x | -0.02 | CHF 0.85 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.9% Upside | Upgrade to Pro+ | |
Xlife Sciences | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 119.43M | 11.8x | 0.32 | CHF 18.45 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curatis Holding | Switzerland | Healthcare | Pharmaceuticals | CHF 54.59M | -0.1x | CHF 11.25 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Relief Therapeutics | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 40.13M | -0.4x | CHF 3.22 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
SHL Telemedicine | Switzerland | Healthcare | Healthcare Providers & Services | CHF 34.59M | -4.4x | 1.13 | CHF 2.11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Addex Therapeutics Ltd | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 5.70M | 1x | -0 | CHF 0.06 | -5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Spexis | Switzerland | Healthcare | Pharmaceuticals | CHF 676.64K | -0.2x | CHF 0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |